Bioresponsive Polymeric Nanoparticles: From Design, Targeted Therapy to Cancer Immunotherapy
Biomacromolecules · 2025
DOI: 10.1021/acs.biomac.4c01257 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomacromolecules, 2025. Verfasst von Huanli Sun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Polymers Laboratory, College of Chemistry, Chemical Engineering and Materials Science, and State Key Laboratory of Radiation Medicine and …. Hauptthemen laut MEDLINE: Immunotherapy, Nanoparticles, Neoplasms, Polymers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 124 Literaturangaben. Gefördert von: Natural Science Research of Jiangsu Higher Education Institutions of China, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biomedical Polymers Laboratory, College of Chemistry, Chemical Engineering and Materials Science, and State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, PR China.
- College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, PR China.
- International College of Pharmaceutical Innovation, Soochow University, Suzhou, 215222, PR China.
ORCID-Profile: Huanli Sun, Zhiyuan Zhong
Förderung
- Natural Science Research of Jiangsu Higher Education Institutions of China
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Sun, H., & Zhong, Z. (2025). Bioresponsive Polymeric Nanoparticles: From Design, Targeted Therapy to Cancer Immunotherapy. Biomacromolecules. https://doi.org/10.1021/acs.biomac.4c01257
Vancouver
Sun H, Zhong Z. Bioresponsive Polymeric Nanoparticles: From Design, Targeted Therapy to Cancer Immunotherapy. Biomacromolecules. 2025. doi:10.1021/acs.biomac.4c01257
BibTeX
@article{Sun2025,
author = {Sun, Huanli and Zhong, Zhiyuan},
title = {Bioresponsive Polymeric Nanoparticles: From Design, Targeted Therapy to Cancer Immunotherapy},
journal = {Biomacromolecules},
year = {2025},
doi = {10.1021/acs.biomac.4c01257}
}
EUVIMED